3 Health Services Stocks Pushing Industry Growth

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 5 points (0.0%) at 16,932 as of Tuesday, June 24, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,934 issues advancing vs. 1,059 declining with 170 unchanged.

The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.2%. Top gainers within the industry include Grifols ( GRFS), up 1.8%, CR Bard ( BCR), up 0.9%, St Jude Medical ( STJ), up 0.6% and Boston Scientific ( BSX), up 0.6%. A company within the industry that fell today was ResMed ( RMD), up 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. UnitedHealth Group ( UNH) is one of the companies pushing the Health Services industry higher today. As of noon trading, UnitedHealth Group is up $0.64 (0.8%) to $82.13 on average volume. Thus far, 1.8 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.3 million shares. The stock has ranged in price between $81.42-$82.38 after having opened the day at $81.43 as compared to the previous trading day's close of $81.49.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $79.8 billion and is part of the health care sector. Shares are up 8.2% year-to-date as of the close of trading on Monday. Currently there are 15 analysts who rate UnitedHealth Group a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full UnitedHealth Group Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Express Scripts ( ESRX) is up $0.41 (0.6%) to $69.06 on light volume. Thus far, 1.5 million shares of Express Scripts exchanged hands as compared to its average daily volume of 5.5 million shares. The stock has ranged in price between $68.36-$69.13 after having opened the day at $68.72 as compared to the previous trading day's close of $68.65.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $53.2 billion and is part of the health care sector. Shares are down 2.3% year-to-date as of the close of trading on Monday. Currently there are 14 analysts who rate Express Scripts a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Express Scripts Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Medtronic ( MDT) is up $0.38 (0.6%) to $64.52 on average volume. Thus far, 4.2 million shares of Medtronic exchanged hands as compared to its average daily volume of 6.5 million shares. The stock has ranged in price between $63.66-$64.65 after having opened the day at $63.74 as compared to the previous trading day's close of $64.14.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $63.9 billion and is part of the health care sector. Shares are up 11.8% year-to-date as of the close of trading on Monday. Currently there are 12 analysts who rate Medtronic a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Medtronic Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%